Literature DB >> 17562673

Left atrial remodelling in mitral regurgitation--methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study.

David Messika-Zeitoun1, Michael Bellamy, Jean-Francois Avierinos, Jerome Breen, Christian Eusemann, Andrea Rossi, Thomas Behrenbeck, Christopher Scott, Jamil A Tajik, Maurice Enriquez-Sarano.   

Abstract

AIMS: To define accurate and normal range of echocardiographic left atrial (LA) volume measurement and to assess the prevalence, determinants, and outcome implications of LA enlargement in mitral regurgitation (MR). METHODS AND
RESULTS: We prospectively compared LA volume obtained simultaneously by electron beam-computed tomography (EBCT) and by four echocardiographic methods in 33 test patients. Accurate echocardiographic LA volume measurements were obtained only by biplane area-length method with vertical longitudinal-length (r = 0.95, P < 0.0001; 145 +/- 57 vs. 143 +/- 55 mL, P = 0.57). Using this method, the normal range in 100 normal subjects, the physiological determinants and outcome implications of LA enlargement in 320 patients with organic MR were analysed. In normal subjects, indexed to body surface area, LA index (27 +/- 6 mL/m(2)) was not influenced by age or gender and values > or = 40 mL/m(2) were beyond the upper limit of normal. In MR, the most powerful determinants of LA enlargement were higher regurgitant volume (RVol) and atrial fibrillation (AF) (P < 0.0001), followed by older age, female gender, higher left ventricular end-systolic volume, and mass (all P < 0.001). After diagnosis in sinus rhythm, LA index > or = 40 mL/m(2) predicted superiorly and independently to LA diameter the occurrence of AF [adjusted RR 1.48 (1.06-2.16), P < 0.01] and the combined endpoint of death or need for mitral surgery [adjusted RR 1.61 (1.3-2.0), P < 0.0001].
CONCLUSION: LA remodelling can be accurately assessed by echocardiography and LA index > or = 40 mL/m(2) is beyond the normal range. In organic MR, higher LA index is the combined result of multiple physiological effects, provides independent prognostic information, and therefore should be part of a comprehensive echocardiographic examination.

Entities:  

Mesh:

Year:  2007        PMID: 17562673     DOI: 10.1093/eurheartj/ehm199

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  33 in total

1.  The diagnostic accuracy of pocket-size cardiac ultrasound performed by unselected residents with minimal training.

Authors:  Vidar Ruddox; Thomas Muri Stokke; Thor Edvardsen; Jøran Hjelmesæth; Erlend Aune; Morten Bækkevar; Ingvild B Norum; Jan Erik Otterstad
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-23       Impact factor: 2.357

2.  Influence of left atrial and ventricular volumes on the relation between mitral valve annulus and coronary sinus.

Authors:  Antonio Sorgente; Quynh A Truong; Cristina Conca; Jagmeet P Singh; Udo Hoffmann; Francesco F Faletra; Catherine Klersy; Rinky Bhatia; Giovanni B Pedrazzini; Elena Pasotti; Tiziano Moccetti; Angelo Auricchio
Journal:  Am J Cardiol       Date:  2008-07-10       Impact factor: 2.778

3.  Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study.

Authors:  Seisyou Kou; Luis Caballero; Raluca Dulgheru; Damien Voilliot; Carla De Sousa; George Kacharava; George D Athanassopoulos; Daniele Barone; Monica Baroni; Nuno Cardim; Jose Juan Gomez De Diego; Andreas Hagendorff; Christine Henri; Krasimira Hristova; Teresa Lopez; Julien Magne; Gonzalo De La Morena; Bogdan A Popescu; Martin Penicka; Tolga Ozyigit; Jose David Rodrigo Carbonero; Alessandro Salustri; Nico Van De Veire; Ralph Stephan Von Bardeleben; Dragos Vinereanu; Jens-Uwe Voigt; Jose Luis Zamorano; Erwan Donal; Roberto M Lang; Luigi P Badano; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-21       Impact factor: 6.875

4.  Left heart longitudinal deformation analysis in mitral regurgitation.

Authors:  Matteo Cameli; Giulia Elena Mandoli; Dan Nistor; Edoardo Lisi; Alberto Massoni; Felice Crudele; Mario Stricagnoli; Stefano Lunghetti; Sergio Mondillo
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-09       Impact factor: 2.357

5.  Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy.

Authors:  Stefan A Lange; Bernd Ebner; Astrid Wess; Matthias Kögel; Mieczyslaw Gajda; Thomas Hitschold; Jens Jung
Journal:  Clin Res Cardiol       Date:  2012-01-17       Impact factor: 5.460

6.  Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation.

Authors:  Robert A Levine; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

7.  Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Authors:  A Rossi; F L Dini; E Agricola; P Faggiano; G Benfari; P L Temporelli; C Cucco; L Scelsi; C Vassanelli; S Ghio
Journal:  J Echocardiogr       Date:  2018-02-23

Review 8.  Treatment and management of mitral regurgitation.

Authors:  Michele De Bonis; Francesco Maisano; Giovanni La Canna; Ottavio Alfieri
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

9.  Left atrial size and risk for all-cause mortality and ischemic stroke.

Authors:  Alberto Bouzas-Mosquera; Francisco J Broullón; Nemesio Álvarez-García; Elizabet Méndez; Jesús Peteiro; Teresa Gándara-Sambade; Oscar Prada; Víctor X Mosquera; Alfonso Castro-Beiras
Journal:  CMAJ       Date:  2011-05-24       Impact factor: 8.262

10.  Atrial longitudinal strain parameters predict left atrial reverse remodeling after mitral valve surgery: a speckle tracking echocardiography study.

Authors:  Ozkan Candan; Nihal Ozdemir; Soe Moe Aung; Suzan Hatipoglu; Can Yucel Karabay; Ahmet Guler; Cetin Gecmen; Cem Dogan; Onur Omaygenc; Ruken Bengi Bakal
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-30       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.